NFKB1 and gastric carcinoma: Zhu et al (20) investigated the antitumor effects of the NF-κB inhibitor SN50 in gastric carcinoma SGC-7901 cells and revealed that NF-κB inhibition triggers an impairment of cell proliferation and the induction of apoptosis of cancer cells.